Why Ventyx Biosciences Is Trading Higher By 70%, Here Are 46 Stocks Moving In Monday's Mid-Day Session



  • Ventyx Biosciences, Inc. VTYX shares jumped 70.4% to $39.37 after Oppenheimer maintained an Outperform rating on the stock and raised its price target from $40 to $65.
  • NeuroBo Pharmaceuticals, Inc. NRBO gained 69% to $0.4664 after the company announced a 1-for-30 reverse stock split.
  • Arqit Quantum Inc. ARQQ shares climbed 34.7% to $7.53. The company will present at the H.C. Wainwright 24th Annual Global Investment Conference later today.
  • InMed Pharmaceuticals Inc. INM gained 32.5% to $14.60 after the company on Friday announced a $6 million private placement priced at $8.68 per share.
  • Ra Medical Systems, Inc. RMED surged 28% to $0.1865 after the company announced a merger agreement with Catheter Precision. Catheter Precision will become a wholly owned subsidiary of Ra Medical.
  • Vinco Ventures, Inc. BBIG gained 25% to $1.2500.
  • IHS Holding Limited IHS jumped 19.2% to $7.47. IHS Holding, last month, said Q2 EPS results down year-over-year.
  • Gogoro Inc. GGR gained 19.1% to $5.16. Gogoro recently launched its battery-swapping system and Smart scooters in the Tel Aviv metropolitan area.
  • Ribbon Communications Inc. RBBN rose 19% to $3.8450.
  • Allego N.V. ALLG gained 18.3% to $5.23.
  • Regulus Therapeutics Inc. RGLS gained 16.8% to $1.94 after the company announced topline safety and PK data from its Phase 1 SAD clinical trial of RGLS8429. The study demonstrated that RGLS8429 has a favorable safety and PK profile.
  • IDEAYA Biosciences, Inc. IDYA surged 15.6% to $10.70. IDEAYA Biosciences disclosed interim Phase 2 clinical results for darovasertib and crizotinib synthetic lethal combination in metastatic uveal melanoma.
  • Carvana Co. CVNA rose 13.7% to $41.64. Piper Sandler upgraded Carvana from Neutral to Overweight and lowered the price target from $98 to $73.
  • POINT Biopharma Global Inc. PNT gained 13.4% to $9.72 after the company published a poster at ESMO Congress 2022 highlighting updated safety and efficacy data from its Phase 3 SPLASH trial of PNT2002 in metastatic castration-resistant prostate cancer.
  • Sigma Lithium Corporation SGML jumped 12.8% to $28.16.
  • Clovis Oncology, Inc. CLVS rose 12.2% to $1.29 after the company said Rubraca (Rucaparib) as first-line maintenance treatment improves progression-free survival in women with advanced ovarian cancer across disease risk subgroups.
  • Auddia Inc. AUUD surged 12% to $1.40.
  • Shuttle Pharmaceuticals Holdings, Inc. SHPH gained 10.8% to $42.98 after jumping 26% on Friday.
  • Genenta Science S.p.A. GNTA gained 10.6% to $5.30.
  • NIO Inc. NIO surged 10.2% to $21.13 following positive analyst coverage from Deutsche Bank and BofA.
  • NetScout Systems, Inc. NTCT gained 9.7% to $33.70. The company, last month, posted upbeat quarterly earnings.
  • Reborn Coffee, Inc. REBN rose 9.4% to $2.5924. Dennis R Egidi recently reported a 9.5% stake in Reborn Coffee.
  • Eve Holding, Inc. EVEX gained 9.2% to $8.42. United recently announced a $15 million investment in Eve Air Mobility and a conditional purchase agreement for 200 four-seat electric aircraft plus 200 options.
  • Asana, Inc. ASAN gained 9% to $26.87. Asana’s President, CEO and Director Dustin Moskovitz bought a total of 19,273,127 shares at an average price of $18.16.
  • Quhuo Limited QH shares rose 7.5% to $2.96 after the company on Friday said it has determined not to proceed with its proposed offering and sale of securities.
  • Hyperfine, Inc. HYPR rose 7.3% to $1.3090 after declining 6% on Friday. Hyperfine, last month, reported worse-than-expected Q2 EPS and sales results and issued FY22 sales guidance below estimates.
  • Bristol-Myers Squibb Company BMY rose 5.6% to $74.11. The FDA approved Bristol Myers Squibb Co's Sotyktu (deucravacitinib), an allosteric tyrosine kinase 2 (TYK2) inhibitor, for moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy. Atlantic Equities maintained Bristol-Myers Squibb with an Overweight and raised the price target from $83 to $87.
  • Spectrum Pharmaceuticals, Inc. SPPI rose 4.3% to $1.35. The U.S. Food and Drug Administration has approved the company’s lead asset ROLVEDON (eflapegrastim-xnst) injection to decrease the incidence of infection, as manifested by febrile neutropenia.


  • Akari Therapeutics, Plc AKTX shares dropped 25% to $0.7803 after the company announced a $12.75 million registered direct offering.
  • Tuesday Morning Corporation TUEM fell 22.7% to $0.2175 after the company secured commitment for strategic investment from group led by Retail Ecommerce Ventures, the owner of Pier 1 Imports and top consumer brands.
  • Yoshiharu Global Co. YOSH shares fell 22.5% to $3.2301. The company, on Friday, priced its IPO at $4 per share.
  • DICE Therapeutics, Inc. DICE fell 19.6% to $18.20. Stifel, last week, initiated coverage on the stock with a Buy rating and a $37 price target.
  • CleanTech Acquisition Corp. CLAQ dropped 17.7% to $5.02. CleanTech Acquisition and Nauticus Robotics completed business combination to trade under "KITT" effective September 13.
  • Apexigen, Inc. APGN declined 16.6% to $6.35 as the company announced the presentation of new data from a Phase 2 trial evaluating sotigalimab (sotiga) in combination with neoadjuvant chemoradiation for resectable esophageal and gastroesophageal junction (GEJ) cancers.
  • Leap Therapeutics, Inc. LPTX dropped 15.3% to $1.43.
  • Codere Online Luxembourg, S.A. CDRO fell 15.6% to $2.70. Codere Online recently reported Q2 sales results.
  • MOGU Inc. MOGU fell 13.6% to $2.2475. Mogu’s board of directors, on Friday, authorized a new share repurchase program of up to $10 million of its shares.
  • Nuwellis, Inc. NUWE fell 12.1% to $0.7469.
  • Entrada Therapeutics, Inc. TRDA dropped 11.4% to $13.21. Entrada Therapeutics, last month, posted a Q2 loss of $0.74 per share.
  • ShiftPixy, Inc. PIXY fell 9.8% to $31.06 after gaining 11% on Friday.
  • Azure Power Global Limited AZRE dropped 9.3% to $5.32.
  • Great Panther Mining Limited GPL declined 9.2% to $0.2144.
  • Immatics N.V. IMTX fell 9% to $11.69.
  • Ayala Pharmaceuticals, Inc. AYLA dropped 8.7% to $1.7250. Ayala Pharmaceuticals presented interim data from RINGSIDE pivotal Phase 2/3 trial of AL102 show confirmed partial response in desmoid tumors, at ESMO Congress.
  • Burning Rock Biotech Limited BNR declined 7.2% to $3.33.
  • Digital Media Solutions, Inc. DMS fell 6% to $2.0696. Digital Media Solutions shares climbed 72% on Friday after the company received a non-binding go-private proposal from Prism Data for $2.50 per share in cash.
Market News and Data brought to you by Benzinga APIs
Posted In: NewsPenny StocksSmall CapIntraday UpdateMarketsMoversTrading IdeasMid-Day MoversTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!